EGFR inhibition reverses resistance to lenvatinib in hepatocellular carcinoma cells
EGFR inhibition reverses resistance to lenvatinib in hepatocellular carcinoma cells is a paper indexed in ScholarIQ from OpenAlex.
How many citations does EGFR inhibition reverses resistance to lenvatinib in hepatocellular carcinoma cells have?
EGFR inhibition reverses resistance to lenvatinib in hepatocellular carcinoma cells has 59 citations in the OpenAlex counts ScholarIQ stores.
When was EGFR inhibition reverses resistance to lenvatinib in hepatocellular carcinoma cells published?
EGFR inhibition reverses resistance to lenvatinib in hepatocellular carcinoma cells has 2022 year in the ScholarIQ index.
What is the open-access status of EGFR inhibition reverses resistance to lenvatinib in hepatocellular carcinoma cells?
EGFR inhibition reverses resistance to lenvatinib in hepatocellular carcinoma cells has gold oa status in the ScholarIQ index.
What is the DOI of EGFR inhibition reverses resistance to lenvatinib in hepatocellular carcinoma cells?
The DOI for EGFR inhibition reverses resistance to lenvatinib in hepatocellular carcinoma cells is on the source record.
What is the PMID of EGFR inhibition reverses resistance to lenvatinib in hepatocellular carcinoma cells?
The PMID for EGFR inhibition reverses resistance to lenvatinib in hepatocellular carcinoma cells is on the source record.
What is the OpenAlex record for EGFR inhibition reverses resistance to lenvatinib in hepatocellular carcinoma cells?
The OpenAlex for EGFR inhibition reverses resistance to lenvatinib in hepatocellular carcinoma cells is on the source record.